- List
- By Topic
- On Map
- Search Details

"Polymyositis"
Need help? See RSS Feeds
Choose a feed type:

"Polymyositis" (78 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01801917 | Terminated Has Results |
Efficacy and Tolerability of BAF312 in Patients With Polymyositis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
14 | All | 18 Years to 75 Years (Adult, Senior) | NCT01801917 | CBAF312X2205 | April 24, 2013 | August 5, 2016 | August 5, 2016 | March 1, 2013 | January 4, 2018 | January 4, 2018 |
|
|
2 | NCT01906372 | Completed Has Results |
Acthar in Treatment of Refractory Dermatomyositis and Polymyositis |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
12 | All | 18 Years and older (Adult, Senior) | NCT01906372 | PRO13050507 | September 2013 | September 2015 | May 2016 | July 24, 2013 | September 1, 2017 | August 2, 2017 |
|
|
3 | NCT02043548 | Recruiting | Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT02043548 | 0039599 | TIM | October 1, 2014 | July 30, 2018 | January 31, 2019 | January 23, 2014 | November 1, 2017 |
|
|
4 | NCT01813617 | Completed | Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis |
|
|
Observational |
|
Other |
|
|
72 | All | 18 Years and older (Adult, Senior) | NCT01813617 | SweMyoNet 1 Centre of Care Science |
September 2010 | June 2012 | March 19, 2013 | March 19, 2013 |
|
||||
5 | NCT02880527 | Completed | Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy |
|
|
Observational |
|
Other |
|
|
187 | All | 18 Years and older (Adult, Senior) | NCT02880527 | 2013/007/HP | EPIDEMYOSITIS | July 2014 | April 2016 | May 2016 | August 26, 2016 | August 26, 2016 |
|
||
6 | NCT03324152 | Not yet recruiting | Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 18 Years to 70 Years (Adult, Senior) | NCT03324152 | KarolinskaUH1 | HIITmyositis | November 1, 2017 | December 31, 2020 | December 31, 2021 | October 27, 2017 | October 27, 2017 | ||
7 | NCT00533091 | Completed | A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
51 | All | 18 Years and older (Adult, Senior) | NCT00533091 | MI-CP151 | April 2008 | August 2010 | October 2010 | September 21, 2007 | May 28, 2012 |
|
||
8 | NCT01637064 | Unknown † | Dermatomyositis and Polymyositis Registry |
|
|
Observational |
|
Other |
|
|
100 | All | 18 Years to 85 Years (Adult, Senior) | NCT01637064 | ADAPT | ADAPT | April 2013 | December 2015 | July 10, 2012 | November 6, 2015 |
|
|||
9 | NCT01315938 | Unknown † | Abatacept Treatment in Polymyositis and Dermatomyositis |
|
|
Interventional | Phase 2 |
|
Other |
|
|
20 | All | 18 Years to 80 Years (Adult, Senior) | NCT01315938 | 2009-015957-20 | ARTEMIS | January 2011 | December 2012 | June 2013 | March 16, 2011 | March 16, 2011 |
|
|
10 | NCT00335985 | Completed | Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
26 | All | 16 Years to 75 Years (Child, Adult, Senior) | NCT00335985 | 0998-12 | June 2006 | March 2009 | March 2009 | June 12, 2006 | November 5, 2014 |
|
||
11 | NCT01415219 | Completed | Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis |
|
|
Interventional | Phase 2 |
|
Other |
|
|
80 | All | 18 Years to 65 Years (Adult) | NCT01415219 | 2007_0712 2007-A00756-47 PHRC 2006/1916 DGS 2007-0440 |
March 2008 | March 2013 | December 2013 | August 11, 2011 | December 18, 2014 |
|
||
12 | NCT01148810 | Terminated | Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
29 | All | 18 Years to 75 Years (Adult, Senior) | NCT01148810 | CBAF312A2202 2008-006311-21 |
June 2010 | June 2012 | June 2012 | June 22, 2010 | August 1, 2013 |
|
||
13 | NCT00001421 | Completed | Methimazole to Treat Polymyositis and Dermatomyositis |
|
|
Interventional | Phase 2 |
|
NIH |
|
20 | All | Child, Adult, Senior | NCT00001421 | 950139 95-AR-0139 |
June 1995 | April 2001 | December 10, 2002 | March 4, 2008 |
|
||||
14 | NCT00033891 | Completed | Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
14 | All | 18 Years and older (Adult, Senior) | NCT00033891 | 020156 02-AR-0156 |
April 10, 2002 | July 31, 2007 | May 20, 2010 | April 12, 2002 | April 4, 2018 |
|
||
15 | NCT00651040 | Completed Has Results |
Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM |
|
|
Interventional | Phase 3 |
|
Other |
|
|
31 | All | 18 Years to 80 Years (Adult, Senior) | NCT00651040 | 3401 | Prometheus | May 2008 | November 2014 | November 2014 | April 2, 2008 | May 12, 2016 | May 12, 2016 |
|
16 | NCT00866125 | Completed | Hand Function in Patients With Poly- or Dermatomyositis |
|
Observational |
|
Other |
|
31 | All | 18 Years and older (Adult, Senior) | NCT00866125 | 02-078 | April 2002 | August 2002 | March 20, 2009 | March 20, 2009 | |||||||
17 | NCT02881450 | Completed | Epidemiological Study of Inflammatory Myopathies in a French Region |
|
Observational |
|
Other |
|
|
117 | All | Child, Adult, Senior | NCT02881450 | 4963 | PREMIA | January 2012 | December 2013 | August 29, 2016 | August 29, 2016 | |||||
18 | NCT02159651 | Active, not recruiting | A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia |
|
|
Observational |
|
Industry |
|
|
179 | All | Child, Adult, Senior | NCT02159651 | PRGI01 506-MA-PRGI-01 |
April 1, 2014 | January 2020 | January 2020 | June 10, 2014 | March 19, 2018 |
|
|||
19 | NCT02780674 | Completed | A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
36 | All | 18 Years to 65 Years (Adult) | NCT02780674 | D6080C00001 | August 26, 2016 | October 23, 2017 | November 27, 2017 | May 23, 2016 | February 5, 2018 |
|
||
20 | NCT03092154 | Recruiting | Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT03092154 | MYO-HCFMUSP-03 | January 2017 | January 2020 | January 2020 | March 27, 2017 | March 27, 2017 |
|
||
21 | NCT00504348 | Completed | Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus |
|
|
Interventional | Phase 2 Phase 3 |
|
Other / Industry |
|
|
26 | All | 16 Years to 74 Years (Child, Adult, Senior) | NCT00504348 | IICT-FK506-01 | IMPPACT | July 2007 | January 2011 | January 2011 | July 20, 2007 | November 17, 2017 |
|
|
22 | NCT00213629 | Completed | myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies |
|
|
Interventional | Not Applicable |
|
Other |
|
|
100 | All | 18 Years to 76 Years (Adult, Senior) | NCT00213629 | 2003/094/HP | MYOARRAY | November 2004 | July 2010 | July 2010 | September 21, 2005 | February 16, 2012 |
|
|
23 | NCT00106184 | Completed Has Results |
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) |
|
|
Interventional | Phase 2 |
|
Other / NIH / Industry |
|
|
200 | All | 5 Years and older (Child, Adult, Senior) | NCT00106184 | N01 AR042273 5R01AR061298-02 HHSN26420042273C |
March 2006 | February 2010 | August 2010 | March 22, 2005 | March 4, 2015 | March 4, 2015 |
|
|
24 | NCT01171573 | Recruiting | Investigating Genes in Patients With Polymyositis and Dermatomyositis |
|
|
Observational |
|
Other |
|
|
1000 | All | 18 Years to 70 Years (Adult, Senior) | NCT01171573 | Ollier-002 | AOMIC | January 2001 | January 2019 | January 2020 | July 28, 2010 | October 17, 2016 |
|
||
25 | NCT03414086 | Enrolling by invitation | Predictor of Clinical Response to Acthar in Myositis |
|
|
Observational |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Senior) | NCT03414086 | PRO16100125 | November 6, 2017 | May 6, 2018 | May 7, 2018 | January 29, 2018 | January 29, 2018 |
|
|||
26 | NCT00001265 | Recruiting | Study and Treatment of Inflammatory Muscle Diseases |
|
Observational |
|
NIH | 99999999 | All | 16 Years and older (Child, Adult, Senior) | NCT00001265 | 910196 91-AR-0196 |
August 8, 1991 | November 4, 1999 | April 13, 2018 |
|
||||||||
27 | NCT00001261 | Completed | Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies |
|
|
Interventional | Phase 2 |
|
NIH |
|
120 | All | Child, Adult, Senior | NCT00001261 | 900139 90-N-0139 |
May 1990 | July 2002 | November 4, 1999 | March 4, 2008 |
|
||||
28 | NCT01165008 | Completed | Anakinra in Myositis |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
All | 18 Years to 80 Years (Adult, Senior) | NCT01165008 | KS 01 03-144 |
September 2003 | September 2008 | July 19, 2010 | July 19, 2010 |
|
|||||
29 | NCT00017914 | Recruiting | Adult and Juvenile Myositis |
|
Observational |
|
NIH |
|
|
1200 | All | Child, Adult, Senior | NCT00017914 | 940165 94-E-0165 |
June 8, 1994 | June 20, 2001 | April 13, 2018 |
|
||||||
30 | NCT01734369 | Recruiting | Environmental Risk Factors for Myositis in Military Personnel |
|
Observational |
|
NIH |
|
|
300 | All | 18 Years to 90 Years (Adult, Senior) | NCT01734369 | 130015 13-E-0015 |
November 22, 2012 | September 30, 2018 | September 30, 2019 | November 27, 2012 | March 29, 2018 |
|
||||
31 | NCT01432613 | Completed | Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies |
|
|
Interventional | Not Applicable |
|
Other |
|
|
139 | All | 18 Years and older (Adult, Senior) | NCT01432613 | K071204 | DARWIM | December 22, 2010 | February 11, 2016 | November 26, 2016 | September 13, 2011 | March 2, 2018 |
|
|
32 | NCT02971683 | Recruiting | Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
150 | All | 18 Years and older (Adult, Senior) | NCT02971683 | IM101-611 2016-002269-77 |
March 13, 2017 | June 17, 2020 | June 4, 2021 | November 23, 2016 | March 7, 2018 |
|
||
33 | NCT00001167 | Completed | Ultrasound Evaluation of Tongue Movements in Speech and Swallowing |
|
Observational |
|
NIH | 570 | All | Child, Adult, Senior | NCT00001167 | 790101 79-CC-0101 |
August 1979 | November 2004 | November 4, 1999 | March 4, 2008 |
|
|||||||
34 | NCT00138983 | Completed | Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. |
|
|
Interventional | Phase 3 |
|
Other |
|
|
200 | All | 18 Years to 90 Years (Adult, Senior) | NCT00138983 | OG67-STOP-study | May 2000 | November 2003 | August 30, 2005 | November 29, 2006 |
|
|||
35 | NCT00001331 | Completed | Genetic and Family Studies of Inherited Muscle Diseases |
|
Observational |
|
NIH | All | Child, Adult, Senior | NCT00001331 | 930143 93-AR-0143 |
May 1993 | March 2002 | November 4, 1999 | March 5, 2008 |
|
||||||||
36 | NCT00971828 | Unknown † | A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy |
|
Observational |
|
Other |
|
30 | All | 18 Years and older (Adult, Senior) | NCT00971828 | Chinoy-001 | July 2011 | September 2012 | September 2012 | September 4, 2009 | August 15, 2011 |
|
|||||
37 | NCT01482494 | Unknown † | Detection of Pompe Disease in Adult Patients With Myopathies of Uncertain Origin or With Asymptomatic Hyper-CK-emia |
|
Observational |
|
Other | 50 | All | 18 Years and older (Adult, Senior) | NCT01482494 | GZ-2011-10784 | December 2011 | December 2012 | November 30, 2011 | December 1, 2011 |
|
|||||||
38 | NCT00443222 | Completed | Treatment With TNF Blockade, Infliximab, in Patients With Myositis |
|
|
Interventional | Phase 2 Phase 3 |
|
Other / Industry |
|
All | 18 Years and older (Adult, Senior) | NCT00443222 | Remicade myositis | March 5, 2007 | March 5, 2007 | ||||||||
39 | NCT03433638 | Recruiting | Juvenile Dermatomyositis |
|
Observational |
|
Other |
|
|
22 | All | up to 16 Years (Child) | NCT03433638 | 6785 | February 8, 2018 | January 2019 | January 2019 | February 14, 2018 | February 27, 2018 |
|
||||
40 | NCT03432455 | Recruiting | Incidence and Prevalence of Juvenile Dermatomyositis |
|
Observational |
|
Other |
|
|
22 | All | up to 16 Years (Child) | NCT03432455 | 6784 | February 7, 2018 | January 2019 | January 2019 | February 14, 2018 | February 14, 2018 |
|
||||
41 | NCT03293615 | Not yet recruiting | Exercise Capacity of Patients With Dermatomyosis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
45 | All | 18 Years and older (Adult, Senior) | NCT03293615 | 6431 | MIDE | July 1, 2018 | July 1, 2018 | January 1, 2025 | September 26, 2017 | March 27, 2018 | ||
42 | NCT03181893 | Recruiting | A Study In Adults With Moderate To Severe Dermatomyositis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
30 | All | 18 Years to 80 Years (Adult, Senior) | NCT03181893 | C0251002 | January 23, 2018 | October 27, 2019 | March 25, 2020 | June 9, 2017 | March 29, 2018 |
|
||
43 | NCT03002649 | Recruiting | Study of Tofacitinib in Refractory Dermatomyositis |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT03002649 | IRB00084227 | STIR | January 2017 | October 2018 | June 2019 | December 26, 2016 | February 19, 2018 |
|
|
44 | NCT02980198 | Recruiting | Study of IFN-K in Dermatomyositis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
30 | All | 18 Years to 65 Years (Adult) | NCT02980198 | IFN-K-005-DM 2016-000137-52 |
November 2016 | December 2018 | December 2, 2016 | September 11, 2017 |
|
|||
45 | NCT02945345 | Recruiting | Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) |
|
Observational |
|
Other |
|
|
300 | All | 18 Years and older (Adult, Senior) | NCT02945345 | 808230 | CDASI | June 2008 | June 2020 | June 2020 | October 26, 2016 | October 26, 2016 |
|
|||
46 | NCT02728752 | Recruiting | Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
94 | All | 18 Years and older (Adult, Senior) | NCT02728752 | GAM10-08 | IIM | February 27, 2017 | March 2019 | March 2019 | April 5, 2016 | March 5, 2018 |
|
|
47 | NCT02612857 | Active, not recruiting | Trial of IMO-8400 in Adult Patients With Dermatomyositis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
36 | All | 18 Years to 75 Years (Adult, Senior) | NCT02612857 | 8400-211 | 8400-211 | November 2015 | May 16, 2018 | September 2018 | November 24, 2015 | October 11, 2017 |
|
|
48 | NCT02594735 | Recruiting | Abatacept in Juvenile Dermatomyositis |
|
|
Interventional | Phase 4 |
|
Other |
|
|
10 | All | 7 Years and older (Child, Adult, Senior) | NCT02594735 | IRB 111418 | AID | November 2015 | December 2018 | December 2018 | November 3, 2015 | March 20, 2018 |
|
|
49 | NCT02466243 | Active, not recruiting | Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis |
|
|
Interventional | Phase 2 |
|
Industry / NIH / Other |
|
|
22 | All | 18 Years to 70 Years (Adult, Senior) | NCT02466243 | JBT101-DM-001 116313 R21AR066286 |
June 2015 | August 2017 | September 2019 | June 9, 2015 | March 16, 2018 |
|
||
50 | NCT02271165 | Recruiting | Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study |
|
|
Interventional | Early Phase 1 |
|
Other |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT02271165 | 13P.192 | November 2014 | October 2018 | October 22, 2014 | November 10, 2016 |
|
† Study has passed its completion date and status has not been verified in more than two years.